Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-276-6 | CAS number: 3806-34-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
Not carcinogenic; Mosinger (1976)
Key value for chemical safety assessment
Carcinogenicity: via oral route
Link to relevant study records
- Endpoint:
- carcinogenicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Not reported
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: A non-GLP study with limited information on the methodology employed. It is not possible to assess the quality and reliability of the presented results with the information that is available.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 20 male and 20 female rats were dosed daily with 100 mg test material in diet for a period of 2 years. Throughout the study animals were observed for appearance and mortality. An interim sacrifice of 3 male and 3 female rats occurred one year after treatment began. All other surviving animals were sacrificed 2 years after treatment began. All animals that were sacrificed were subjected to a full macroscopic as well as histological examination. Any findings noted were compared to historical control data.
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: International Institute, 25 rue des Colonies - 13008, Marseille, France
- Housing: groups of 5 by sex
- Diet: Laccassagne MAB 1 synthetic feed (ad libitum)
ENVIRONMENTAL CONDITIONS
- Animals were kept in heated and well ventilated rooms - Route of administration:
- oral: feed
- Vehicle:
- not specified
- Details on exposure:
- DIET PREPARATION
100 mg of test material per kg of Laccaggagne feed powder. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 1 year (3 animals per sex); 2 years (all surviving animals)
- Frequency of treatment:
- Daily
- Remarks:
- Doses / Concentrations:
100 mg/kg
Basis:
other: mg test material per kg diet - No. of animals per sex per dose:
- 20 males and 20 females
- Control animals:
- yes, historical
- Observations and examinations performed and frequency:
- Animals were observed for mortality during the study. Appearance was recorded as well as any remarkable signs observed.
- Sacrifice and pathology:
- All surviving to scheduled necropsy were subjected to a comlete macroscopical and histological examination.
- The following tissues were sampled: small intestine, large intestine, spleen, liver, stomach, pancreas, adrenal gland, kidney, testicle, uterine or vesicoprostatic fragments, ovaries, lung, heart, cervix, lymph nodes, salivary glands, thyroid, thymus, brain, bone, pituitary gland, sternum, femur, bone marrow, mesenteric lymph node.
- All fragments were fixed with formalin and stained with toluidine blue
- Liver weigths were recorded. - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- 3 of the animals died prior to scheduled sacrifice
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- 3 of the animals died prior to scheduled sacrifice
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- There were no significant changes in body weight noted between treated and control animals
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- The weight of the liver was comparable amongst treated animals and respective controls
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No gross changes were noted in treated animals that were not observed in control animals
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No anomalies were recorded
- Histopathological findings: neoplastic:
- no effects observed
- Description (incidence and severity):
- only one malignant tumour was noted in animals treated with test material
- Relevance of carcinogenic effects / potential:
- The test material was concluded to be non carcinogenic.
- Conclusions:
- Under the conditions of the study an abdominal tumor was noted; it was an atypical epithelioma. No breast tumor, subcutaneous or hepatic spindle-cell sarcoma, or adenohypophysial adenoma was noted. Thus, only one malignant tumor (2.5 %) in the animals treated with the test material. This was below the rate of incidence in the control animals.
- Executive summary:
The carcinogenicity of the test material was determined in a study in which 20 male and 20 female rats were dosed daily with 100 mg test material in diet for a period of 2 years. Throughout the study animals were observed for appearance and mortality. An interim sacrifice of 3 male and 3 female rats occurred one year after treatment began. All other, surviving, animals were sacrificed 2 years after treatment began. All animals that were sacrificed were subjected to a full macroscopic as well as histological examination. Any findings noted were compared to historical control data. Under the conditions of the study 3 animals died prematurely, however, no clinical signs were noted and no significant differences in bodyweights were noted. No remarkable signs were seen at histology other than an abdominal tumor which was noted in one animal which was found to be an atypical epithelioma. No breast tumor, subcutaneous or hepatic spindle-cell sarcoma, or adenohypophysial adenoma was noted. Thus, only one malignant tumor (2.5 %) in the animals treated with the test material. This was below the rate of incidence in the control animals.
Reference
Bodyweights:
- At autopsy, the treated males weighed from 290 to 410 g. The weight variations of the males were comparable to the variations noted in the control animals. At autopsy the treated female bodyweights varied between 260 to 330 g. These variations were comparable to the control females.
Histological anatomical observations:
- Mycoplsamal chronic bronchopneumopathy was noted in 7 animals. This condition also exists with the same frequency in control animals.
- Suppurative sphenoidal sinusitis was noted in 2 animals with basilar abscess. Such phenomena are also observed in control animals.
- In the digestive tract there was absence of pharyngeal and esophageal lesions, hemorrhagic gastric foci were found in one animals which was also affected by sinusitis. Moreover, an abdominal tumor of the atypical epithelioma type was noted in one animals and a granulomatous inflammatory process in the rectum in another.
- Liver weight variation was consistent in treated and control animals. Other observations of the liver were as follows: hepatic steatosis processes were observed in 7 animals, a reactive start of Küpfer's cells were observed in 2 animals, a liver of cardiac appearance was observed in one animal. However, such processes are also noted in high frequency in the control animals.
- The spleen was found to be hypertrophic or reactive in the animals affected by pulmonary mycoplasmosis
- Hyperplasia of the spleen was noted in 3 animals
- A cystic nephrosis was noted in 2 animals. Such a condition is found in high frequency in the control animals.
- An interstitial adenoma was noted in a testicle of one animal. This conditions was observed frequently in control animals.
- The uterine mucosa of one animals was hyperplastic. This was also noted frequently in female control animals.
- Diencephalomeningeal reactions were observed in the animals affected by sphenoidal sinusitis with basilar abcess. Incidences of this reaction was also recorded in control animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- The study was not conducted to GLP. The report includes limited information on the methodology employed. It is therefore not possible to assess the quality and reliability of the presented results with the information that is available. The study was assigned a reliability score of 4 according to the criteria of Klimisch (1997).
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation 1272/2008, the test material does not require classification for carcinogenicity. The effects observed in the one available study are not considered to be toxicologically significant and are below the incidence in the control animals.
Additional information
The carcinogenicity of the test material was determined in Mosinger (1976), in which 20 male and 20 female rats were dosed daily with 100 mg test material in diet for a period of 2 years. Throughout the study animals were observed for appearance and mortality. An interim sacrifice of 3 male and 3 female rats occurred one year after treatment began. All other, surviving, animals were sacrificed 2 years after treatment began. All animals that were sacrificed was subjected to a full macroscopic as well as histological examination. Any findings noted were compared to historical control data. Under the conditions of the study 3 animals died prematurely, however, no clinical signs were noted and no significant differences in bodyweights were noted. No remarkable signs were seen at histology other than an abdominal tumor which was noted in one animal which was found to be an atypical epithelioma. No breast tumor, subcutaneous or hepatic spindle-cell sarcoma, or adenohypophysial adenoma was noted. Thus, only one malignant tumor (2.5%) in the animals treated with the test material. This was below the rate of incidence in the control animals. The study was reported in limited detail (a translated summary of the original study). The study was therefore assigned a reliability score of 4 in accordance with the principles for assessing data quality as defined in Klimisch (1997).
Justification for selection of carcinogenicity via oral route endpoint:
Only one study is available.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.